Article
C1q Knock-Out Mice for the Study of Complement Deficiency in Autoimmune Disease
1 Jan 1998
Abstract excerpt
In humans, homozygous deficiency of the first component of the classical pathway of complement, C1q, is a powerful disease susceptibility factor for the development of systemic lupus erythematosus (SLE). This strong association indicates that a functional activity of C1q protects from the development of SLE. Studies in vitro have shown that C1q can bind apoptotic keratinocytes suggesting that it may have an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
